| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
BoostCTR is one of the fastest growing B2B SaaS companies in Silicon Valley, and we are committed to going public. We're hiring across the company in all roles. Join us as we revolutionize the digital advertising industry! With 500% YoY growth, BoostCTR is privately held with financing from Battery Ventures, Javelin Venture Partners and Metamorphic Ventures. We raised our Series A in December of 2012 and our Series B in June of 2013. BoostCTR is an enterprise solution for optimizing ad creative at scale across Search, Social, Display & Mobile. Boost increases advertiser profitability by using a combination of humans and software to drive increased ad relevance at scale. The Boost marketplace is comprised of over 1,000 expert copywriters and image optimizers who compete to provide a diverse array of perspectives. Boost’s proprietary software identifies opportunities for optimization and drives performance using a combination of workflow tools and algorithms.
Synchrono® software for Lean and Demand-Driven manufacturing production planning, production scheduling, ekanban, operations and a visual factory.
In 2008, Malwarebytes was founded on the belief that you and everyone have a fundamental right to a malware-free existence. Every product we make is built on that premise. Malwarebytes Anti-Malware is designed and coded by folks like you. Folks who have stayed up all night trying to rescue an infected machine. Folks who have dealt with the aftereffects of a hacked email account or a compromised business network. We work around the world—Europe, Asia, and America—and around the clock. Tweaking our unique blend of heuristic, signature, and behavior-based technologies to protect people like you and businesses like yours. Because malware never sleeps. We believe that brilliant code can make the world a better place for all of us. We hope Malwarebytes Anti-Malware can make it better for you.